Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment

Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment

PurposeAccurate risk stratification can improve lymphoma management, but current volumetric 18F-fluorodeoxyglucose (FDG) indicators require time-consuming segmentation of all lesions in the body. Herein, we investigated the prognostic values of readily obtainable metabolic bulk volume (MBV) and bulk...

Full description

Bibliographic Details
Main Authors: Hyun Jin, Myung Jin, Chae Hong Lim, Joon Young Choi, Seok-Jin Kim, Kyung-Han Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Oncology
Subjects:
lymphoma
DLBCL
PET/CT
(18)F-FDG
bulky
metabolic tumor volume
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1186311/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1186311/full

Similar Items